Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention ...

Basis Medical announced the completion of the first-in-human clinical procedures using the company’s Seclusion catheter to t ...

BioStem Technologies, Inc., a developer of placental-derived products for wound care, recently announced that patient ...

The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

7. Ezzeldin M, Ota R, Riha E, et al. Use of angled-tip aspiration catheters is associated with a lower cost of thrombectomy ...

Teleflex: Manta Vascular Closure Device Bioresorbable implant: Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035: Indicated for closure of femoral artery access sites while reducing ...

Crossroads Neurovascular, Inc. announced FDA 510(k) clearance for the company’s Path balloon guide catheter (BGC) for neurov ...

StentIt, a Netherlands-based developer of stents with regenerative properties, announced the successful implantation of its resorb ...

June 23, 2025—Gore & Associates announced that the company’s TAG thoracic branch endoprosthesis (TBE) has received FDA approval for use in zones 0 and 1, expanding its indication for the endovascular ...

Venous return is attained through a complex interaction of valves, muscle pumps, and pressure gradients and is greatly influenced by position. In the upright position, gravity is counteracted by the ...